DIN 02528339 — SCEMBLIX 40 MG
SCEMBLIX is a tablet of Asciminib marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Asciminib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02528339
- Brand name
- SCEMBLIX
- Active ingredient
- Asciminib
- Strength
- 40 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- BCR::ABL1 tyrosine kinase inhibitor (STAMP inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Asciminib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02528320 | SCEMBLIX | 20 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |